Risk of Diabetes Associated With Cancer Development-In Reply

Juhee Cho^{1

2

3}, Danbee Kang^{1

2}, Yul Hwangbo⁴, Eliseo Guallar^{1

2

3}

Affiliations

¹ Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea.
² Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
³ Welch Center for Epidemiology, Prevention, and Clinical Research, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
⁴ Division of Endocrinology, Department of Internal Medicine, National Cancer Center, Goyang, South Korea.

Comment

Juhee Cho et al. JAMA Oncol. 2019.

. 2019 Mar 1;5(3):429-430.

doi: 10.1001/jamaoncol.2018.6647.

Juhee Cho^{1

2

3}, Danbee Kang^{1

2}, Yul Hwangbo⁴, Eliseo Guallar^{1

2

3}

¹ Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea.
² Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
³ Welch Center for Epidemiology, Prevention, and Clinical Research, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
⁴ Division of Endocrinology, Department of Internal Medicine, National Cancer Center, Goyang, South Korea.

No abstract available

Comment on

Incidence of Diabetes After Cancer Development: A Korean National Cohort Study.
Hwangbo Y, Kang D, Kang M, Kim S, Lee EK, Kim YA, Chang YJ, Choi KS, Jung SY, Woo SM, Ahn JS, Sim SH, Hong YS, Pastor-Barriuso R, Guallar E, Lee ES, Kong SY, Cho J. Hwangbo Y, et al. JAMA Oncol. 2018 Aug 1;4(8):1099-1105. doi: 10.1001/jamaoncol.2018.1684. JAMA Oncol. 2018. PMID: 29879271 Free PMC article.
Risk of Diabetes Associated With Cancer Development.
Hu D, Peng F, Niu W. Hu D, et al. JAMA Oncol. 2019 Mar 1;5(3):429. doi: 10.1001/jamaoncol.2018.6619. JAMA Oncol. 2019. PMID: 30653207 No abstract available.